13F reference period
Q3 2026
CUSIP: M96088105
13F reference period
Q3 2026
Institutions Reporting
166
Shares (Excl. Options)
Price
$40.63
The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
Latest holder context comes from 166 institutions filings for Q3 2026.
Security key
M96088105
13F reference period
Q3 2026
13F holders
166
13D/G owners
8
CIK / CUSIP context first
Broader feeds
Open recent reporting periods for CUSIP M96088105:
13D/G owners
Large-stake holder rows connected to Schedule 13D/G evidence.
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 6.3% | +22% | $124,273,174 | +$21,894,626 | 3,058,648 | +21% | BlackRock, Inc. | 30 Sep 2026 |
| TORONTO DOMINION BANK | 5.7% | -14% | $106,000,478 | -$19,108,077 | 2,770,530 | -15% | The Toronto-Dominion Bank | 30 Sep 2026 |
| MORGAN STANLEY | 5.4% | +180% | $35,433,378 | +$24,712,637 | 2,488,299 | +231% | Morgan Stanley | 30 Jun 2025 |
| MENORA MIVTACHIM HOLDINGS LTD. | 5% | $24,780,614 | 2,303,031 | Menora Mivtachim Holdings Ltd | 11 Mar 2025 | |||
| Soleus Capital Master Fund, L.P. | 4.7% | -6% | $31,114,400 | -$1,993,600 | 2,185,000 | -6% | Soleus Capital Master Fund, L.P. | 30 Jun 2025 |
| Paradigm Biocapital Advisors LP | 3.5% | -61% | $34,556,086 | -$50,946,098 | 1,703,949 | -60% | Paradigm BioCapital Advisors LP | 31 Mar 2026 |
| Adage Capital Management, L.P. | 2.8% | -60% | $13,740,520 | -$17,765,685 | 1,277,000 | -56% | Adage Capital Management, L.P. | 31 Mar 2025 |
| Monograph Capital Holdings Advisors, LLC | 1.8% | $8,503,556 | 838,615 | Monograph Capital Partners I, L.P. | 05 Jun 2025 |
13F concentration
Largest 13F positions for this security by reported shares and value.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 9.3% | 4,543,895 | 1.9% | $184,618,454 | |
| Kynam Capital Management, LP | 5% | 2,434,207 | 5.5% | $98,901,830 | |
| Jefferies Financial Group Inc. | 4.5% | 2,199,652 | 1.2% | $89,371,861 | |
| ACORN CAPITAL ADVISORS, LLC | 3.4% | 1,648,420 | 18% | $66,975,305 | |
| Opaleye Management Inc. | 3% | 1,439,996 | 6.6% | $58,507,037 | |
| SILVERARC CAPITAL MANAGEMENT, LLC | 2.4% | 1,148,689 | 5.7% | $46,671,234 | |
| ORBIMED ADVISORS LLC | 2% | 988,487 | 0.74% | $40,162,227 | |
| STATE STREET CORP | 2% | 975,787 | 0% | $39,646,226 | |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 1.9% | 936,144 | 0.41% | $38,035,534 | |
| MPM BIOIMPACT LLC | 1.9% | 909,691 | 2.8% | $36,960,745 | |
| GOLDMAN SACHS GROUP INC | 1.7% | 848,342 | 0% | $34,468,135 | |
| Migdal Insurance & Financial Holdings Ltd. | 1.6% | 770,909 | 0.19% | $31,322,033 | |
| Parkman Healthcare Partners LLC | 1.5% | 750,202 | 2.7% | $30,480,707 | |
| GEODE CAPITAL MANAGEMENT, LLC | 1.3% | 617,513 | 0% | $25,086,227 | |
| Woodline Partners LP | 1% | 500,726 | 0.06% | $20,344,497 | |
| Boxer Capital Management, LLC | 1% | 500,000 | 1.8% | $20,315,000 | |
| Elmind Capital, LP | 1% | 491,100 | 4.9% | $19,953,393 | |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 0.95% | 462,075 | 0% | $18,774,107 | |
| TWO SIGMA INVESTMENTS, LP | 0.84% | 406,299 | 0.01% | $16,507,928 | |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 0.75% | 366,973 | 0.02% | $14,910,113 | |
| Hennion & Walsh Asset Management, Inc. | 0.64% | 309,584 | 0.37% | $12,578,398 | |
| FEDERATED HERMES, INC. | 0.63% | 305,217 | 0.02% | $12,400,967 | |
| NEXT CENTURY GROWTH INVESTORS LLC | 0.61% | 297,083 | 0.77% | $12,070,482 | |
| Schonfeld Strategic Advisors LLC | 0.61% | 295,809 | 0.06% | $12,018,718 | |
| Qube Research & Technologies Ltd | 0.59% | 287,222 | 0.01% | $11,669,830 |
Quarter history
Holder count, reported shares/value, and median price by quarter.
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q3 | 32,436,707 | $1,317,563,240 | -$42,090,067 | $40.63 | 166 |
| 2026 Q2 | 42,380,184 | $1,559,593,252 | -$44,922,069 | $36.80 | 188 |
| 2026 Q1 | 46,442,204 | $835,175,547 | +$44,201,709 | $17.98 | 172 |
| 2025 Q4 | 43,711,574 | $1,023,591,933 | +$14,662,063 | $23.42 | 167 |
| 2025 Q3 | 43,904,765 | $877,180,169 | +$94,297,658 | $19.95 | 159 |
| 2025 Q2 | 39,798,464 | $545,161,051 | +$3,475,596 | $13.70 | 149 |
| 2025 Q1 | 41,643,932 | $460,619,197 | +$59,835,372 | $11.06 | 139 |
| 2024 Q4 | 36,306,231 | $386,611,717 | -$9,614,830 | $10.65 | 139 |
| 2024 Q3 | 35,097,143 | $445,735,362 | -$58,506,168 | $12.70 | 127 |
| 2024 Q2 | 38,225,503 | $641,423,803 | +$207,327,873 | $16.78 | 114 |
| 2024 Q1 | 27,162,024 | $407,381,837 | +$84,866,378 | $15.00 | 111 |
| 2023 Q4 | 21,390,291 | $320,854,510 | +$51,912,609 | $15.00 | 103 |
| 2023 Q3 | 17,724,118 | $248,330,352 | +$65,704,038 | $14.01 | 100 |
| 2023 Q2 | 13,209,673 | $136,728,106 | +$7,180,182 | $10.35 | 84 |
| 2023 Q1 | 12,428,895 | $114,822,764 | -$4,446,429 | $9.24 | 64 |
| 2022 Q4 | 13,022,042 | $115,449,037 | -$2,381,858 | $8.87 | 63 |
| 2022 Q3 | 13,319,758 | $110,811,074 | -$981,981 | $8.32 | 56 |
| 2022 Q2 | 13,444,839 | $109,243,080 | -$6,040,297 | $8.19 | 60 |
| 2022 Q1 | 14,223,995 | $123,920,902 | +$1,868,931 | $8.71 | 82 |
| 2021 Q4 | 14,650,914 | $139,360,752 | +$2,176,410 | $9.51 | 71 |
| 2021 Q3 | 14,085,432 | $236,906,894 | +$1,235,828 | $16.82 | 88 |
| 2021 Q2 | 13,993,075 | $213,691,867 | -$5,527,357 | $15.27 | 78 |
| 2021 Q1 | 14,299,652 | $278,497,797 | -$4,203,728 | $19.48 | 88 |
| 2020 Q4 | 14,549,849 | $261,548,580 | -$10,506,654 | $18.02 | 81 |
| 2020 Q3 | 15,009,007 | $288,527,801 | +$6,244,867 | $19.29 | 78 |